רני בטעם תפוז ישראל - עברית - Ministry of Health

רני בטעם תפוז

bayer israel ltd - calcium carbonate; magnesium carbonate - טבליות לעיסות - calcium carbonate 680 mg; magnesium carbonate 80 mg - combinations - combinations - relief of hyperacidity and heartburn.

רני אייס ישראל - עברית - Ministry of Health

רני אייס

bayer israel ltd - calcium carbonate; magnesium carbonate - טבליות לעיסות - calcium carbonate 680 mg; magnesium carbonate 80 mg - combinations - combinations - relief of hyperacidity and heartburn.

פליט אנמה 133 ישראל - עברית - Ministry of Health

פליט אנמה 133

dexcel ltd, israel - sodium phosphate; sodium phosphate - חוקן - sodium phosphate 60 mg/ml; sodium phosphate 160 mg/ml - combinations - combinations - cleaning the colon before surgery, child birth or medical examinations.

פליט אנמה 250 ישראל - עברית - Ministry of Health

פליט אנמה 250

dexcel ltd, israel - sodium phosphate; sodium phosphate - חוקן - sodium phosphate 60 mg/ml; sodium phosphate 160 mg/ml - combinations - combinations - cleaning the colon before surgery, child birth or medical examinations.

ויטליפיד אן מבוגרים ישראל - עברית - Ministry of Health

ויטליפיד אן מבוגרים

cure medical & technical supply - ergocalciferol; phytomenadione; retinol palmitate; tocopherol - תרכיז להכנת תמיסה לאינפוזיה - phytomenadione 15 mcg/ml; ergocalciferol 0.5 mcg/ml; tocopherol 0.91 mg/ml; retinol palmitate 194.1 mcg/ml - combinations - combinations - vitalipid n adult is indicated in adult and children above 11 years of age as a supplement in iv nutrition to meet the daily requirement of the fat soluble vitamins a, d2, e,k1.

ליפופונדין אם.סי.טיאל.סי.טי % 10 ישראל - עברית - Ministry of Health

ליפופונדין אם.סי.טיאל.סי.טי % 10

lapidot medical import and marketing ltd - soya oil; triglycerides, medium-chain - תחליב לאינפוזיה - triglycerides, medium-chain 50 mg/ml; soya oil 50 mg/ml - combinations - combinations - source of calories and essential fatty oils for patients requiring parenteral nutrition

ליפופונדין אם.סי.טיאל.סי.טי % 20 ישראל - עברית - Ministry of Health

ליפופונדין אם.סי.טיאל.סי.טי % 20

lapidot medical import and marketing ltd - soya oil; triglycerides, medium-chain - תחליב לאינפוזיה - soya oil 100 mg/ml; triglycerides, medium-chain 100 mg/ml - combinations - combinations - source of calories and essential fatty oils for patients requiring parenteral nutrition.

אוויסל ישראל - עברית - Ministry of Health

אוויסל

omrix biopharmaceuticals ltd, israel - calcium chloride; protein clottable; thrombin - תמיסה - thrombin 800 - 1200 iu / 1 ml; calcium chloride 5.6 - 6.20 mg / 1 ml; protein clottable 50 - 90 mg / 1 ml - combinations - combinations - general haemostasis : evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. efficacy has been demonstrated in liver surgery and orthopaedic surgery.

דקסטרוז % 5 ו - % 0.9 סודיום כלוריד הנתרן להזרקה ישראל - עברית - Ministry of Health

דקסטרוז % 5 ו - % 0.9 סודיום כלוריד הנתרן להזרקה

teva medical ltd - glucose as monohydrate; sodium chloride - תמיסה לאינפוזיה - glucose as monohydrate 5 %; sodium chloride 0.9 % - combinations - combinations - intravenous solutions are indicated as a source of water, electrolytes and/or calories.

גרדסיל ישראל - עברית - Ministry of Health

גרדסיל

merck sharp & dohme israel ltd - protein l1 (type 11); protein l1 (type 16); protein l1 (type 18); protein l1 (type 6) - תרחיף להזרקה - protein l1 (type 18) 20 mcg / 0.5 ml; protein l1 (type 6) 20 mcg / 0.5 ml; protein l1 (type 11) 40 mcg / 0.5 ml; protein l1 (type 16) 40 mcg / 0.5 ml - combinations - combinations - gardasil is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, and 18 (which are included in the vaccine). gardasil is indicated in males 9 through 26 years* of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, and 18 (which are included in the vaccine). *immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations..